Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Chavanel

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1986
Antigenic variants of the nonspecific cross-reacting antigen (NCA)P Burtin, G Chavanel, J C Hendrick, et al.
Oncodevelopmental Biology and Medicine : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 1, 1983
Production of monoclonal antibodies against the non-specific cross-reacting antigen (NCA)G Chavanel, N Frenoy, M J Escribano, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|January 1, 1976
An optical and ultrastructural study of the localization of carcinoembryonic antigen (CEA) in normal and cancerous human rectocolonic mucosaE Huitric, R Laumonier, P Burtin, et al.
British Journal of Cancer|December 1, 1978
Leucocyte-migration-inhibition test in patients with colorectal cancer: clinicopathological correlationsP Burtin, C Pinset, E Chany, et al.
Journal of Immunological Methods|March 1, 1991
EBV cell-lines (LCL) and E- cells as stimulator cells for limiting dilution analysis (LDA) of alloreactive IL-2-secreting cells (IL-2-SC) and cytotoxic precursors (CTLp). Comparison of their stimulator capacity and ability to generate specific alloreactivityO Lantz, P Alard, G Chavanel, et al.
Transplantation|February 1, 1993
A possible role for specific "anergy" in immunologic hyporeactivity to donor stimulation in human kidney allograft recipientsP Alard, O Lantz, J Y Perrot, et al.
Cancer|June 1, 1977
Use of a permanent cell line extracts to study the tumor associated immune reactions in colorectal cancer patients by leucocyte migration inhibition testP Burtin, E Chany, R Beaulieu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 15, 1990
Persistence of donor-specific IL-2-secreting cells and cytotoxic T lymphocyte precursors in human kidney transplant recipients evidenced by limiting dilution analysisO Lantz, P Alard, M H Ben Aribia, et al.
Gene Therapy|August 1, 1996
Antifection: an antibody-mediated method to introduce genes into lymphoid cells in vitro and in vivoP Poncet, A Panczak, C Goupy, et al.
Biotechniques|October 1, 1993
A versatile ELISA-PCR assay for mRNA quantitation from a few cellsP Alard, O Lantz, M Sebagh, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1986
Antigenic variants of the nonspecific cross-reacting antigen (NCA)P Burtin, G Chavanel, J C Hendrick, et al.
Oncodevelopmental Biology and Medicine : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 1, 1983
Production of monoclonal antibodies against the non-specific cross-reacting antigen (NCA)G Chavanel, N Frenoy, M J Escribano, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|January 1, 1976
An optical and ultrastructural study of the localization of carcinoembryonic antigen (CEA) in normal and cancerous human rectocolonic mucosaE Huitric, R Laumonier, P Burtin, et al.
British Journal of Cancer|December 1, 1978
Leucocyte-migration-inhibition test in patients with colorectal cancer: clinicopathological correlationsP Burtin, C Pinset, E Chany, et al.
Journal of Immunological Methods|March 1, 1991
EBV cell-lines (LCL) and E- cells as stimulator cells for limiting dilution analysis (LDA) of alloreactive IL-2-secreting cells (IL-2-SC) and cytotoxic precursors (CTLp). Comparison of their stimulator capacity and ability to generate specific alloreactivityO Lantz, P Alard, G Chavanel, et al.
Transplantation|February 1, 1993
A possible role for specific "anergy" in immunologic hyporeactivity to donor stimulation in human kidney allograft recipientsP Alard, O Lantz, J Y Perrot, et al.
Cancer|June 1, 1977
Use of a permanent cell line extracts to study the tumor associated immune reactions in colorectal cancer patients by leucocyte migration inhibition testP Burtin, E Chany, R Beaulieu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 15, 1990
Persistence of donor-specific IL-2-secreting cells and cytotoxic T lymphocyte precursors in human kidney transplant recipients evidenced by limiting dilution analysisO Lantz, P Alard, M H Ben Aribia, et al.
Gene Therapy|August 1, 1996
Antifection: an antibody-mediated method to introduce genes into lymphoid cells in vitro and in vivoP Poncet, A Panczak, C Goupy, et al.
Biotechniques|October 1, 1993
A versatile ELISA-PCR assay for mRNA quantitation from a few cellsP Alard, O Lantz, M Sebagh, et al.
Pageof 4